Literature DB >> 26592925

Even the normal is abnormal: N-heterocyclic carbene C(2) binding to a phosphaalkene without breaking the P=C π-bond.

Paresh Kumar Majhi1, Keith C F Chow2, Tom H H Hsieh2, Eric G Bowes2, Gregor Schnakenburg3, Pierre Kennepohl2, Rainer Streubel3, Derek P Gates2.   

Abstract

The reaction of MesP=CPh2 with the least sterically demanding N-heterocyclic carbene (NHC = IMe) results in formation of the 'abnormal' (C(4)-substituted) 4-phosphino-NHC (1). In contrast, reaction with Me2IMe gives the unprecedented 'normal' C(2) adduct, Me2IMe → P(Mes)=CPh2 (2). Particularly striking is the asymmetric and weak bonding of the NHC to the P=C moiety in 2. DFT calculations indicate that the P=C natural bond order in 2 (1.54) still reflects significant π-character to the bond (cf. MesP=CPh2: NBO = 1.98). Further computational analysis suggests that π-delocalization into the remote C-phenyl substituents is key to stabilizing the NHC adduct.

Entities:  

Year:  2016        PMID: 26592925     DOI: 10.1039/c5cc08181e

Source DB:  PubMed          Journal:  Chem Commun (Camb)        ISSN: 1359-7345            Impact factor:   6.222


  3 in total

1.  Reactivity enhancement of a diphosphene by reversible N-heterocyclic carbene coordination.

Authors:  Debabrata Dhara; Pankaj Kalita; Subhadip Mondal; Ramakirushnan Suriya Narayanan; Kaustubh R Mote; Volker Huch; Michael Zimmer; Cem B Yildiz; David Scheschkewitz; Vadapalli Chandrasekhar; Anukul Jana
Journal:  Chem Sci       Date:  2018-03-27       Impact factor: 9.825

Review 2.  Functionalised N-Heterocyclic Carbene Ligands in Bimetallic Architectures.

Authors:  Kieren J Evans; Stephen M Mansell
Journal:  Chemistry       Date:  2020-03-18       Impact factor: 5.236

3.  Synthesis of a 1-Aryl-2,2-chlorosilyl(phospha)silene Coordinated by an N-Heterocyclic Carbene.

Authors:  Andreas Wolfgang Kyri; Paresh Kumar Majhi; Takahiro Sasamori; Tomohiro Agou; Vitaly Nesterov; Jing-Dong Guo; Shigeru Nagase; Norihiro Tokitoh; Rainer Streubel
Journal:  Molecules       Date:  2016-09-30       Impact factor: 4.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.